Results 251 to 260 of about 2,570,818 (334)
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang+16 more
wiley +1 more source
Editorial: Mucosal immunity after vaccination. [PDF]
Arish M, López-Siles M, Naz F.
europepmc +1 more source
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin+10 more
wiley +1 more source
Promiscuity and specificity in ligand sensing by plant cell surface receptors. [PDF]
Steidele CE+4 more
europepmc +1 more source
STUDIES ON DENGUE FEVER I. STUDIES ON DENGUE VIRUS AND IMMUNITY. (2)
N. Ishii
openalex +2 more sources
ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan+46 more
wiley +1 more source
The short chitooligosaccharide CO4 inhibits chitin-triggered immunity in grapevine and promotes the infection by Botrytis cinerea but not Plasmopara viticola. [PDF]
Marzari T+8 more
europepmc +1 more source
ABSTRACT The pathogenesis of Sydenham chorea remains unclear. We report a 10‐year‐old girl presenting with subacute chorea and mild carditis following Streptococcal throat infection. Single‐cell RNA sequencing on 30,794 peripheral immune cells from the patient and two sex‐matched controls revealed nine immune cell clusters.
Velda X. Han+9 more
wiley +1 more source
Detection of Immunity Gap before Measles Outbreak, Ho Chi Minh City, Vietnam, 2024. [PDF]
Ong T+30 more
europepmc +1 more source